Stock SOPH SOPHIA GENETICS SA
Add to a list
To use this feature you must be a member
Log inSign up

SOPHiA GENETICS SA Stock

Equities

SOPH

CH1125843347

Software

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-19 pm EDT 		5-day change 1st Jan Change
4.96 USD +3.33% Intraday chart for SOPHiA GENETICS SA -0.80% +5.31%
Apr. 17 SOPHiA GENETICS Announces Unilabs Using Its AI Technology to Detect Homologous Recombination Deficiency CI
Apr. 04 Sophia Genetics Forms Partnership With Strand Life Sciences to Advance Diagnostic Tools MT

Financials (USD)

Sales 2024 * 79.36M Sales 2025 * 101M Capitalization 313M
Net income 2024 * -66M Net income 2025 * -53M EV / Sales 2024 * 3.25 x
Net cash position 2024 * 55.31M Net cash position 2025 * 15.14M EV / Sales 2025 * 2.96 x
P/E ratio 2024 *
-4.75 x
P/E ratio 2025 *
-6.05 x
Employees 430
Yield 2024 *
-
Yield 2025 *
-
Free-Float 79.82%
More Fundamentals * Assessed data

Chart SOPHiA GENETICS SA

Dynamic Chart

Latest news about SOPHiA GENETICS SA

SOPHiA GENETICS Announces Unilabs Using Its AI Technology to Detect Homologous Recombination Deficiency CI
Sophia Genetics Forms Partnership With Strand Life Sciences to Advance Diagnostic Tools MT
Sophia Genetics SA Announces Laboratorio Barnafi-Krause Is Live on the Sophia DDM? Platform CI
SOPHiA GENETICS Announces First Homologous Recombination Deficiency Customer in Canada CI
Transcript : SOPHiA GENETICS SA, Q4 2023 Earnings Call, Mar 05, 2024
SOPHiA GENETICS SA Provides Earnings Guidance for 2024 CI
SOPHiA GENETICS SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
North American Morning Briefing : S&P 500 Futures -2- DJ
Sophia Genetics, AstraZeneca Expand Project to Improve Access to Ovarian Cancer Testing in Spain MT
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain CI
Sophia Genetics Supports Genetic Testing in Brazil CI
SOPHiA GENETICS Enhances RareCyte Inc. Precision Biology Services Portfolio CI
SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India CI
Transcript : SOPHiA GENETICS SA Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 09:00 AM
SOPHiA GENETICS SA Provides Preliminary Earnings Guidance for the Full Year Ending December 31, 2023 CI
More news

Latest transcript on SOPHiA GENETICS SA

Logo SOPHiA GENETICS SA
SOPHiA GENETICS SA, Q4 2023 Earnings Call, Mar 05, 2024
More transcripts

Analyst Recommendations on SOPHiA GENETICS SA

RBC Initiates SOPHiA GENETICS at Outperform With $8 Price Target, Notes 'Attractive' Entry Point, Exposure to Long-Term Growth in Sequencing, Life Science Research MT
Credit Suisse Raises SOPHiA GENETICS' Price Target to $5 From $2.25 After 'Solid' Q1 Results, Keeps Neutral Rating MT
Morgan Stanley Trims Price Target on Sophia Genetics to $10 From $11, Maintains Overweight Rating MT
Morgan Stanley Adjusts Price Target on SOPHiA GENETICS to $11 From $12, Maintains Overweight Rating MT
BTIG Starts SOPHiA GENETICS at Buy With $6 Price Target MT
More recommendations

Press releases SOPHiA GENETICS SA

SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD) PR
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership AQ
Laboratorio Barnafi-Krause is Live on SOPHiA DDM™ PR
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada PR
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration AQ
More press releases

News in other languages on SOPHiA GENETICS SA

Un triumvirat à la tête de Swisscom Ventures
Las mejores acciones para ganar en bolsa en Wall Street en 2024
AstraZeneca : partenariat renforcé avec Sophia Genetics
Les sociétés suisses ont préféré l'étranger pour entrer en Bourse
Schweizer Unternehmen bevorzugten 2021 Börsengang im Ausland
More news

Quotes and Performance

1 day-1.03%
1 week-4.00%
Current month-2.64%
1 month+10.85%
3 months+6.43%
6 months+49.53%
Current year+1.91%
More quotes

Highs and lows

1 week
4.70
Extreme 4.7
5.01
1 month
4.50
Extreme 4.5
5.34
Current year
4.00
Extreme 4
7.37
1 year
2.13
Extreme 2.13
7.37
3 years
1.69
Extreme 1.685
19.80
5 years
1.69
Extreme 1.685
19.80
10 years
1.69
Extreme 1.685
19.80
More quotes

Managers and Directors - SOPHiA GENETICS SA

Managers TitleAgeSince
Jurgi Camblong FOU
 Founder 45 10-12-31
Ross Muken DFI
 Director of Finance/CFO 44 21-01-31
Abhimanyu Verma CTO
 Chief Tech/Sci/R&D Officer - 22-01-09
Members of the board TitleAgeSince
Didier Hirsch BRD
 Director/Board Member 72 20-05-31
Vincent Ossipow BRD
 Director/Board Member 55 14-05-31
Kathy Hibbs BRD
 Director/Board Member 60 21-02-28
More insiders

Quotes

Date Price Change Volume
24-04-19 4.96 +3.33% 51 047
24-04-18 4.8 -1.03% 66,018
24-04-17 4.85 -2.61% 150,391
24-04-16 4.98 +2.47% 20,148
24-04-15 4.86 -2.80% 57,828

Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT

More quotes

Company Profile

Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.
Sector
Software
Calendar
2024-05-06 - Q1 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for SOPHiA GENETICS SA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.8 USD
Average target price
8.667 USD
Spread / Average Target
+80.56%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

1st Jan change Capi.
SOPHIA GENETICS SA Stock SOPHiA GENETICS SA
+1.91% 313M
MICROSOFT CORPORATION Stock Microsoft Corporation
+7.52% 3,004B
SYNOPSYS INC. Stock Synopsys Inc.
+0.93% 79.28B
CADENCE DESIGN SYSTEMS, INC. Stock Cadence Design Systems, Inc.
+4.97% 77.94B
DASSAULT SYSTÈMES SE Stock Dassault Systèmes SE
-13.76% 53.9B
ATLASSIAN CORPORATION Stock Atlassian Corporation
-18.60% 50.22B
PALANTIR TECHNOLOGIES INC. Stock Palantir Technologies Inc.
+23.06% 46.76B
THE TRADE DESK, INC. Stock The Trade Desk, Inc.
+12.30% 39.49B
SEA LIMITED Stock Sea Limited
+39.01% 31.91B
TAKE-TWO INTERACTIVE SOFTWARE, INC. Stock Take-Two Interactive Software, Inc.
-12.62% 23.99B
Other Software
  1. Stock Market
  2. Equities
  3. SOPH Stock